insurance changes to glp 1 drugs Medicare GLP-1 Drug Coverage Patients Face New Barriers for

OAT, organic anion transporter

Based on the study results, in early March the FDA approved the use of injectable semaglutide to reduce the risk of cardiovascular death, myocardial infarction and stroke in adults with cardiovascular disease who are obese or overweight

As GLP-1 medications become more widely used for metabolic health and weight management, interest in needle-free alternatives has surged

Let us look at the side effects of GLP-1 agonists: Loss of appetite Nausea Vomiting Diarrhoea Dizziness Mild tachycardia (fast heartbeat)

Over the past decades, researchers overcame significant challenges such as the hormones very short half-life in the body to develop long-acting GLP-1 receptor agonist drugs